[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[EP-tech] Is EPrints 3.4 and beyond open source software?
Thank you Tomasz for bringing this up.
Personally I'm worried too.
We just launched a 3.3.15 based product and one of the main reasons for choosing EPrints instead of some commercial package was its open source licence and support for the open access effort.
I am also worried because, in the case of a change like this, I would personally stop contributing to EPrints, and I think that many others will simply do the same.
On June 29, 2017 5:22:17 AM GMT+10:00, Tomasz Neugebauer <Tomasz.Neugebauer at concordia.ca> wrote:
>It is time to bring up the question of whether or not EPrints 3.4 and
>beyond is open source software.
>The answer to this question is determined by the license under which
>EPrints 3.4 is distributed.
>These are Open Source software licenses:
>EPrints 3.3 has a GPL license.
>What about EPrints 3.4? Is it distributed under a GPL license?
>I ask this, because Eprints Services keeps referring to something
>called "managed availability", is that a new license?
>The name "managed availability" doesn't sound like the name of an open
>source license, but perhaps "managed availability" doesn't refer to a
>new (closed source?) license, and EPrints 3.4 is still distributed
>under a GPL license?
>What would be the equivalent of "managed availability" in the world of
>journal article availability? Not open access, right?
>I think we deserve to have a clear answer to this, so that we can think
>about the implications for the community that has contributed to
>I saw on a slide from EPrints Services during the OR conference
>something like this:
>"Open source software models have their limitations"
>That may be so, but I, for one, am deeply committed to open source
>software in the open access repository space.
>Open source is a value and a culture. It also has many advantages, and
>I probably don't need to list in detail on this list because you are
>all well aware of them, but let me just use a quote from a 2010 paper
>where I commented on my choice of EPrints:
>"low initial cost, accessibility to evaluation without a limited trial
>period, availability to develop software enhancements without the need
>to convince a corporation of the enhancement's financial viability".
Sent from my Android device with K-9 Mail. Please excuse my brevity.
-------------- next part --------------
An HTML attachment was scrubbed...